Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriersLiesbeth E M Oosten, Els Blokland, Michel G D Kester, et al.Blood|March 20, 2004
Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytesLiesbeth E M Oosten, Els Blokland, Astrid G S van Halteren, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimersAlison M E Whitelegg, Liesbeth E M Oosten, Susan Jordan, et al.International Immunology|September 15, 2007
TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytesLiesbeth E M Oosten, Danijela Koppers-Lalic, Els Blokland, et al.Vaccines|November 27, 2021
Longitudinal Dynamics of Human B-Cell Response at the Single-Cell Level in Response to Tdap VaccinationIndu Khatri, Annieck M Diks, Erik B van den Akker, et al.Vaccines|April 27, 2026
Flow Cytometric Assessment of Pertactin- and Tetanus Toxoid-Specific B-Cell Kinetics After Tdap Booster Vaccination in Healthy AdultsMirjam J Esser, Annieck M Diks, Liesbeth E M Oosten, et al.Journal of Crohn'S & Colitis|December 19, 2018
Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn's Fistulas: A Case ReportMarieke C Barnhoorn, Astrid G S Van Halteren, Melissa Van Pel, et al.Frontiers in Immunology|June 28, 2021
Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster VaccinationAnnieck M Diks, Indu Khatri, Liesbeth E M Oosten, et al.European Journal of Haematology|August 8, 2018
Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision modelFrederick W Thielen, Hedwig M Blommestein, Liesbeth E M Oosten, et al.The Journal of Allergy and Clinical Immunology|November 6, 2022
Comprehensive overview of autoantibody isotype and subclass distributionMikhail Volkov, Mariateresa Coppola, Ruth Huizinga, et al.Pageof 2